Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
64,175.47 +1,698.23 (+2.72%) CMC Crypto 200
1,371.97 +59.34 (+4.52%)
STAAR Surgical Company (STAA)
After hours:
| Previous close | 46.77 |
| Open | 46.51 |
| Bid | 46.26 x 300 |
| Ask | 46.56 x 300 |
| Day's range | 46.00 - 47.33 |
| 52-week range | 26.66 - 73.13 |
| Volume | |
| Avg. volume | 726,482 |
| Market cap | 2.267B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 107.88 |
| EPS (TTM) | 0.43 |
| Earnings date | 01 May 2024 - 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 48.28 |
ZacksStrength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
Staar Surgical (STAA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BenzingaEye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus
Thursday, STAAR Surgical Company (NASDAQ:STAA) reported preliminary net sales for the first quarter of 2024 of more than $77 million versus the consensus of $72.13 million, with U.S. ICL sales expected to be $5 million for the quarter. This represents the company’s highest quarterly ICL sales in the U.S. since the company obtained U.S. FDA approval for the EVO ICL in March 2022. “STAAR is off to a solid start in 2024 as illustrated by our preliminary first quarter results, including a record qua
Simply Wall St.Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
